Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790133 | Urologic Oncology: Seminars and Original Investigations | 2018 | 15 Pages |
Abstract
miR-181a is up-regulated in ccRCC and may act as a tumor promoting factor by targeting KLF6 expression. Manipulating miR-181a may provide a beneficial effect in the treatment of ccRCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zhenwei M.D., Xin M.D., Hongzhao M.D., Yu M.D., Yu M.D., Yang M.D., Xintao M.D., Luyao M.D., Yongpeng M.D., Jianwen M.D., Shengpan M.D., Lu M.D., Xu M.D.,